Quarterly report [Sections 13 or 15(d)]

License Agreement (Details Narrative)

v3.25.1
License Agreement (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Sep. 28, 2022
May 31, 2021
May 31, 2020
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Jun. 30, 2024
Research and development expense       $ 638,324 $ 748,339 $ 3,173,718 $ 3,081,231  
Number of shares of common stock 1              
Preferred stock, par value       $ 0.001   $ 0.001   $ 0.001
Vernalis Development Limited [Member]                
Research and development expense     $ 150,000          
Development milestone payment     29,900,000          
Vernalis Development Limited [Member] | IPO [Member]                
Number of shares of common stock   192,857            
Preferred stock, par value   $ 0.001            
Future milestone payments   $ 1,400,000            
Vernalis Development Limited [Member] | Minimum [Member]                
Marketing authorization amount     400,000          
Sales milestone payments     10,000,000.0          
Cumulative annual net sales amount     500,000,000.0          
Vernalis Development Limited [Member] | Maximum [Member]                
Marketing authorization amount     3,000,000.0          
Sales milestone payments     25,000,000.0          
Cumulative annual net sales amount     $ 1,000,000,000.0